This inventor holds 1 USPTO granted patent. Top assignee: Roche Diagnostics Gmbh. Active years: 2002.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2002
Title: Norbert Schroeder: Innovator in Biochemical Reagents
Introduction
Norbert Schroeder is a notable inventor based in Schwetzingen, Germany. He has made significant contributions to the field of biochemistry, particularly in the development of reagents used for medical diagnostics. His work has implications for the accurate measurement of important biomarkers in biological samples.
Latest Patents
Norbert Schroeder holds a patent for a "Stabilized reagent and method for determining creatine kinase." This invention involves a stabilized reagent for the photometric enzymatic determination of creatine kinase (CK) in biological sample material. The reagent works by forming ATP from creatine phosphate and ADP, allowing for the detection of the ATP formed. Notably, the reagent is stable at temperatures between 2 to 8°C for up to 12 months without significant loss of function. This innovation enhances the reliability of CK measurements, which are crucial in various medical assessments.
Career Highlights
Schroeder is associated with Roche Diagnostics GmbH, a leading company in the field of medical diagnostics. His work at Roche has allowed him to focus on developing high-quality reagents that improve diagnostic accuracy. His patent reflects his commitment to advancing medical technology and improving patient care.
Collaborations
Norbert has collaborated with esteemed colleagues such as Rolf Nagel and Juergen Mistele. These partnerships have fostered an environment of innovation and have contributed to the successful development of his patented technologies.
Conclusion
Norbert Schroeder's contributions to the field of biochemistry through his patented inventions demonstrate his dedication to improving medical diagnostics. His work continues to impact the healthcare industry positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
